APA

Paoloni M., Webb C., Mazcko C., Cherba D., Hendricks W., Lana S., Ehrhart E. J., Charles B., Fehling H., Kumar L., Vail D., Henson M., Childress M., Kitchell B., Kingsley C., Kim S., Neff M., Davis B., Khanna C. & Trent J. (20150106). Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trials. : PloS one.

Chicago

Paoloni Melissa, Webb Craig, Mazcko Christina, Cherba David, Hendricks William, Lana Susan, Ehrhart E J, Charles Brad, Fehling Heather, Kumar Leena, Vail David, Henson Michael, Childress Michael, Kitchell Barbara, Kingsley Christopher, Kim Seungchan, Neff Mark, Davis Barbara, Khanna Chand and Trent Jeffrey. 20150106. Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trials. : PloS one.

Harvard

Paoloni M., Webb C., Mazcko C., Cherba D., Hendricks W., Lana S., Ehrhart E. J., Charles B., Fehling H., Kumar L., Vail D., Henson M., Childress M., Kitchell B., Kingsley C., Kim S., Neff M., Davis B., Khanna C. and Trent J. (20150106). Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trials. : PloS one.

MLA

Paoloni Melissa, Webb Craig, Mazcko Christina, Cherba David, Hendricks William, Lana Susan, Ehrhart E J, Charles Brad, Fehling Heather, Kumar Leena, Vail David, Henson Michael, Childress Michael, Kitchell Barbara, Kingsley Christopher, Kim Seungchan, Neff Mark, Davis Barbara, Khanna Chand and Trent Jeffrey. Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trials. : PloS one. 20150106.